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Summary
 
Mouse mammary tumor virus (MMTV[SW]) encodes a superantigen expressed by infected B
cells. It evokes an antibody response specific for viral envelope protein, indicating selective ac-
tivation of antigen-specific B cells. The response to MMTV(SW) in draining lymph nodes was
compared with the response to haptenated chicken gamma globulin (NP-CGG) using flow cy-
tometry and immunohistology. T cell priming occurs in both responses, with T cells proliferat-
ing in association with interdigitating dendritic cells in the T zone. T cell proliferation contin-
ues in the presence of B cells in the outer T zone, and B blasts then undergo exponential
growth and differentiation into plasma cells in the medullary cords. Germinal centers develop
in both responses, but those induced by MMTV(SW) appear later and are smaller. Most T cells
activated in the T zone and germinal centers in the MMTV(SW) response are superantigen
specific and these persist for weeks in lymph nodes draining the site MMTV(SW) injection;
this contrasts with the selective loss of superantigen-specific T cells from other secondary lym-
phoid tissues. The results indicate that this viral superantigen, when expressed by professional
antigen-presenting cells, drives extrafollicular and follicular B cell differentiation leading to vi-
rus-specific antibody production.
 
M
 
ouse mammary tumor virus (MMTV)
 
1
 
 is a type B
retrovirus with a life cycle that is tightly linked to
the immune system. Only days after birth, suckling mice
are infected by milk-borne MMTV. Infection is first de-
tected among the B cells of the Peyer’s patches. The key
event then is the expression of a viral protein called super-
antigen (SAg) on the B cell surface; this is encoded in the
3
 
9
 
 long terminal repeat of MMTV (reviewed in reference 1).
The superantigens encoded by MMTV are presented ex-
clusively in the context of class II MHC and are recognized
by whole families of T helper cells that have a V
 
b
 
 element
of their TCR in common. T cells expressing the appropri-
ate V
 
b
 
 undergo a SAg-induced proliferative response and
in this way have the potential to provide unlimited cognate
T help to MMTV-infected B cells. This strong local T–B
interaction is responsible for the amplification of the in-
fected B cell pool, allowing life-long survival of the virus
within the host (2, 3). The mobility of infected lympho-
cytes is an important feature of the spread of MMTV to
other organs, particularly to the mammary gland where the
life cycle starts again.
The effect of SAg expression on the fate of immune cells
in the periphery has been studied in detail by injection of
bacterial or viral SAg into adult mice (4–8). The lymph node
immune response to footpad injection of MMTV(SW) shows
the following sequence of events. The B cells are preferen-
tially infected and express a SAg that is reactive with V
 
b
 
6.
CD4
 
1
 
 T cells expressing V
 
b
 
6 subsets are then activated by
the SAg and grow in number during the first 3–6 d. These
activated T cells help to initiate the expansion of the in-
fected B cells, which proliferate on day 5–6 when peak in-
fection levels in the lymph node are reached (8). Finally,
these B cells become plasma cells and reach a maximum of
IgG-secreting cells on day 6 (9).
Primary responses to conventional protein antigens have
been investigated in more detail. They generally require a
stage of T cell priming on APCs competent in presenting
antigen in combination with potent costimulation. This typi-
cally involves antigen presentation by interdigitating den-
dritic cells (IDC), whose precursors have taken up antigen
 
1
 
Abbreviations used in this paper:
 
 IDC, interdigitating dendritic cells;
MMTV, mouse mammary tumor virus; NP-CGG, haptenated chicken
gamma globulin; PNA, peanut agglutinin; SAg, superantigen.
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in the tissues and migrated to the T zones of secondary
lymphoid organs (reviewed in reference 10). This priming
process usually takes 2–4 d in vivo and is the main reason
for the difference in the tempo of primary and secondary
antibody responses (11, 12). Cognate interaction between
primed T cells and B cells first takes place in the outer T zone
of secondary lymphoid organs (12–14). As a result of this
interaction, Ag-specific B cells start to proliferate and dif-
ferentiate in parallel in follicles and in extrafollicular foci.
Extrafollicular B blasts do not mutate their Ig V-region
genes (15, 16), and they differentiate in situ into short-lived
plasma cells (17, 18). In mice, this extrafollicular prolifera-
tion and differentiation occurs in the red pulp of the spleen
adjacent to the T zone (13, 19) and in the medullary cord
in lymph nodes (20). B cell proliferation in the follicles
gives rise to germinal centers where the B blasts activate an
Ig V region–directed hypermutation mechanism (16, 21, 22).
These cells are then subject to a selection process, with the
selected cells giving rise to long-lived antibody-producing
cells (17, 23) or memory cells (24).
Some aspects of the in vivo immune response to
MMTV(SW) closely resemble the response to MHC class II–
restricted peptides. In both there is clonal expansion of Ag-
reactive CD4
 
1
 
 cells, Ag-driven collaboration between B cells
and CD4
 
1
 
 T cells, and the proliferation and differentiation
of the B cells into antibody-forming cells. Other features of
the SAg-induced immune response are less well character-
ized; some of these are addressed in this study: (
 
a
 
) does the
response to MMTV(SW), which encodes a SAg, require
T cell priming and, if so, what is the cell that induces the
priming? (
 
b
 
) If T cell priming is required, does it occur
more rapidly in the presence of an effectively unlimited
number of antigen-reactive T cells? V
 
b
 
6
 
1
 
 T cells, which
are activated by the SAg of MMTV(SW), comprise some
10% of the CD4
 
1
 
 T cells in BALB/c mouse secondary
lymphoid tissues. (
 
c
 
) What are the sites, extent, and timing
of B and T cell proliferation and differentiation in response
to SAgs or retroviruses in vivo? (
 
d
 
) Is the antibody produc-
tion induced by injection of MMTV(SW) intrinsically
polyspecific or is it mainly directed against viral antigens?
These points have been addressed in experiments that
have compared the immune response to MMTV(SW) infec-
tion in vivo with the response to (4-hydroxy-3-nitrophenyl)
acetyl conjugated to chicken gamma globulin (NP-CGG).
Quantitative data on cell populations in the draining lymph
node have been provided by three-color flow cytometry
analysis, while the sites of T and B cell activation were de-
termined in parallel by three-color immunohistology. The
results point to a remarkable similarity between the cellular
interactions that occur between SAg-dependent responses
and those that are driven by recognition of peptide pre-
sented on MHC class II molecules.
 
Materials and Methods
 
Mice.
 
BALB/c mice were purchased from HO Harlan
OLAC Ltd. (Bicester, UK). 
 
Mtv7
 
 (Mls1
 
a
 
) congenic BALB/c
(BALB.D2) mice were bred from breeding pairs originally ob-
tained from H. Festenstein (London Hospital Medical College,
London). MMTV(SW)-infected BALB/c mice were maintained
from mice originally purchased from IFFA Credo (L’Arbesle,
France).
 
Antigens and Immunizations.
 
Groups of adult (6–12 wk) BALB/c
and BALB.D2 mice were injected into both hind footpads with
MMTV(SW) (
 
z
 
10
 
8
 
 virus particles) purified from milk as de-
scribed previously (7) or a corresponding volume of MMTV-free
milk from BALB/c mice. NP (Cambridge Research Biochemi-
cals, Northwich, UK) was conjugated to CGG (Sigma Chemical
Co., St. Louis, MO) and precipitated in alum (Sigma) as described
elsewhere (25). Groups of BALB/c mice were injected into both
hind footpads with 25 
 
m
 
g alum-precipitated NP-CGG together
with 5 
 
3
 
 10
 
8
 
 killed 
 
Bordetella pertussis
 
 organisms (Lederle Labs.,
Gosport, UK). Control mice were injected either with alum-pre-
cipitated NP-CGG or protein-free alum precipitate with 
 
B. per-
tussis
 
 alone.
 
Tissue Preparation.
 
The thymidine analog 5-bromo-2
 
9
 
-deox-
yuridine (BrdU) (Sigma) was administered as 2 mg in saline i.p.
2.5 h before sacrifice. This was to label cells in S phase of the cell
cycle. The animals were killed by CO
 
2
 
 asphyxiation, when blood
was taken and the draining popliteal lymph nodes were removed.
Those tissues used for immunohistology were wrapped in alu-
minium foil, snap-frozen in liquid N
 
2
 
, and stored at 
 
2
 
70
 
8
 
C in
grip-sealed polythene bags until sections were cut. The frozen
lymph nodes were embedded in OCT compound (Miles, Inc.,
Elkhart, IN) in a defined orientation and 5 
 
m
 
m cryostat sections
were mounted onto 4-spot glass slides. These were air dried for 1 h,
then fixed in acetone at 4
 
8
 
C for 20 min, dried, and stored in
sealed polythene bags at 
 
2
 
20
 
8
 
C.
 
Flow Cytometry Reagents and Antibodies.
 
Flow cytometry re-
agents were as follows: anti-V
 
b
 
6–FITC or biotin (44.22.1) (26),
anti-V
 
b
 
14–FITC (14.2) (27), anti-CD4–PE (GK1.5) (Boehringer
Mannheim GmbH, Mannheim, Germany), anti-CD8–PE (Ly-2)
(Boehringer Mannheim), anti-B220–FITC or PE (6A3-6B2) (Cal-
tag, San Francisco, CA), anti-IgD–biotin (AMS 9.1) (PharMin-
gen, San Diego, CA), peanut agglutinin (PNA) biotin (Sigma,
Buchs, Switzerland), streptavidin–Tricolor (Caltag), anti-BrdU–
FITC (Becton Dickinson & Co., Palo Alto, CA).
 
Flow Cytometry.
 
One of the two draining popliteal lymph
nodes was used for analysis of cell subsets and their proliferation,
whereas the other was processed for histology. To analyze the
surface markers, lymph node cells were labeled with different
combinations of antibodies listed above and analyzed on a FACScan
 
Ò
 
(Becton-Dickinson & Co., Mountain View, CA) using Lysis II
software for data evaluation. To analyze cells in S phase of the cell
cycle on the basis of BrdU uptake, cells were first surface labeled
using PE and Tricolor-conjugated reagents. After washing, cells
were resuspended in cold 0.15 M NaCl and fixed by dropwise
addition of cold 95% ethanol. Cells were left 0.5 h on ice,
washed, and incubated in 100 
 
m
 
l PBS containing 1% para-
formaldehyde and 0.01% Tween-20 overnight. Cells were pel-
leted, then incubated with 15 U/ml DNAase I (Pharmacia Bio-
tech AG, Duebendorf, Switzerland) in 0.15 M NaCl, 4.2 mM
MgCl
 
2
 
, pH 5, for 30 min at 37
 
8
 
C. Cells were washed, incubated
for 30 min with anti-BrdU–FITC (Becton Dickinson), washed
again, and analyzed on FACScan
 
Ò
 
.
 
Histological Reagents and Antibodies.
 
The rat mAbs anti-V
 
b
 
6
(44.22.1), anti-V
 
b
 
14 (14.2), anti-CD3 (17A2), anti-CD4 (H129),
and anti-B220 (14.8) were used as culture supernatants. Sheep
anti-IgD (Binding Site Ltd., Birmingham, UK) and mouse anti-
BrdU (Dako Ltd., High Wycombe, UK) were used as purified
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IgG. The following biotinylated reagents were used: rat anti-syn-
decan-1 and mouse anti-MHC II (14-4-4S) (PharMingen); rabbit
anti-MMTV(SW) gp52 and rabbit preimmune sera were gifts from
F. Luethi (Lausanne, Switzerland); PNA (Sigma). NP-binding
cells and CGG-binding cells were identified using NP conjugated
to rabbit IgG and biotinylated CGG, respectively. As a second
stage, where alkaline phosphatase was to be used, nonbiotinylated
antibodies were treated with one of the following biotinylated
antibodies: rabbit anti–rat Ig, swine anti–rabbit Ig, or goat anti–
mouse Ig (Dako Ltd.). Sheep anti–mouse IgD was detected using
peroxidase-conjugated donkey anti–sheep Ig (Binding Site Ltd.).
Biotinylated reagents were detected with StreptABComplex alka-
line phosphatase.
 
Immunohistological Staining.
 
Tissue sections were double-stained
for IgD with CD3, CD4, V
 
b
 
6, V
 
b
 
14, syndecan-1, and PNA and
also for B220, MHC II, and MMTV gp52 localization. Both NP
and CGG-binding B cells were localized in tissue sections as de-
scribed in reference 19. Slides were washed for 10 min in Tris-
buffered saline (pH 7.6) (TBS) before adding predetermined dilu-
tions of the primary Ab in TBS. These were incubated for 1 h at
room temperature, then washed extensively in two changes of
buffer. The second reagents were added to the sections and incu-
bated for 45 min. After further washes, StreptABComplex alka-
line phosphatase was added and the sections incubated for 30 min.
Enzyme substrates were made up as previously described in refer-
ence 28. Sections were developed first for peroxidase activity us-
ing 3-3
 
9
 
 diaminobenzidine (Sigma), then for alkaline phosphatase
using the substrate Naphthol AS-MX phosphate and chromogen
Fast Blue BB salt; levamisole (Sigma) was used to block endoge-
nous alkaline phosphatase activity.
Slides were washed in two changes of distilled H
 
2
 
O for 10 min
before treating for 20 min with 1 M HCl at 60
 
8
 
C. This not only
exposes the incorporated BrdU within the tissue but also destroys
the activity of previously bound immunohistological reagents.
Slides were returned to water, then two changes of buffer, before
anti-BrdU was added. This was detected with biotinylated goat
anti–mouse Ig, then StreptABComplex–alkaline phosphatase. En-
zyme activity was demonstrated using Naphthol AS-MX phos-
phate with Fast Red TR salt (Sigma).
 
ELISA Techniques.
 
Plastic plates with 96 flat-bottomed wells
were coated overnight at 4
 
8
 
C with 5 
 
m
 
g/ml of either NP-BSA or
recombinant viral envelope protein gp52 in carbonate buffer (pH
9.6). Plates were washed with PBS plus 0.05% Tween-20, then
blocked with 1% BSA. After washing, dilutions of the test sera
were added and incubated during 4 h at room temperature. A
balanced mixture of four mouse IgG anti-gp52 mAb and a high
titer anti NP immune serum were used as controls to produce
standard calibration curves to determine antibody titers. Bound
Ab was detected using biotinylated anti-mouse IgG (Amersham
Rahn, Zurich, Switzerland) followed by streptavidin-conjugated
alkaline phosphatase (Boehringer Mannheim GmbH). Plates were
developed with 
 
p
 
-Nitrophenyl-phosphate (Sigma) and absor-
bance read at 405 nm. Serum titers were calculated using the cal-
ibration curve to give an OD
 
50
 
 of the standard controls.
 
Results
 
The Experimental Approach.
 
BALB/c mice were in-
jected into both hind footpads with milk-purified infec-
tious MMTV(SW) or alum-precipitated NP-CGG with
killed 
 
B. pertussis
 
 microorganisms. The specific serum anti-
body titers of these immunized mice were measured and
the immune responses in the draining popliteal LN were
compared. To assess the proliferative response, mice were
given a pulse of BrdU i.p. 2.5 h before death to identify
and localize cells that had been in S phase of the cell cycle
over this period. One draining popliteal LN was used to
quantify cellular subsets by flow cytometry; the contralat-
eral draining LN was used to colocalize these subsets by
immunohistology. With both methods, cells were stained
for cell differentiation and proliferation markers between
day 0 and day 30 after antigen challenge. The antibody re-
sponses are shown in Fig. 1, while the flow cytometry data
are shown in Figs. 2 and 4 and the histological analyses in
Figs. 3, 5, 6, 7.
 
Serum Antibody Responses Indicate that Ag-specific T and B
Cells Interact Efficiently.
 
Serum antibody titers were as-
sessed against recombinant viral envelope protein gp52 (Fig.
1 
 
a
 
) and NP (Fig. 1 
 
b
 
). Specific IgG antibody to both gp52
and NP are detectable respectively from day 3 and day 5,
peaking around day 5 and day 8. Thereafter, the antibody
titers remain relatively constant through day 30.
Figure 1. Kinetics of antigen-specific serum IgG antibody responses
following immunization with MMTV(SW) or NP-CGG into both foot-
pads. (a) shows the titers against bacterially derived recombinant viral en-
velope protein gp52 of mice injected with MMTV(SW), and (b) shows
the anti-NP titers in mice immunized with alum-precipitated NP-CGG
plus B. pertussis. Shown are the individual values (squares) as well as the
mean (line).
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Figure 2. Flow cytometric
analysis of T and B cell numbers
and proliferative responses.
BALB/c mice were immunized
into both footpads with MMTV
(SW) (a, c, e), or alum-precipi-
tated NP-CGG with B. pertussis
(b, d, f). Cell suspensions of the
draining popliteal LN were ana-
lyzed at different times after im-
munization. a and b show the
mean numbers of B2201 cells,
CD41 cells, and CD81 cells, per
popliteal LN. c and d show the
mean numbers of CD41, Vb61,
and CD41, Vb62 cells that had
incorporated BrdU during the
2.5 h before the nodes were re-
moved. e and f show the mean
number of CD42 cells that had
incorporated BrdU. Extrapola-
tion from histology suggests that
the CD42 blasts are mainly B
blasts. a also shows results for
BALB.D2 mice immunized with
MMTV(SW) while b, d, f also
show the results for BALB/c
mice immunized with alum-pre-
cipitated NP-CGG without B.
pertussis or mice given protein-
free alum precipitate plus B. per-
tussis. Three mice were analyzed
for each immunization at each
timepoint.
Figure 3. Histological localiza-
tion of cells proliferating within
the T zone (T) of lymph nodes
draining MMTV(SW) infection.
Cells incorporating BrdU dur-
ing a 2.5-h pulse are identified
by red staining nuclei in all pan-
els. a (3100) shows MHC class
II expression (blue) 2 d after chal-
lenge with MMTV(SW); large
interdigitating cells are seen in
the T zone where very few cells
are proliferating. The smaller
class II1 cells at the edge of the
panel are follicular (F) B cells. b–d
(3500) show the T zone from a
lymph node taken 3 d after in-
fection with MMTV(SW). At
this stage there are large numbers
of BrdU1 cells in that area.
These are associated with IDC
stained blue for MHC class II
expression in b; they are not ob-
viously associated with B cells
stained blue for B220 expression
in c and they are largely Vb61 as
indicated by blue staining in d
where recirculating IgD1 B cells
are stained brown.
555 Luther et al.
T Cell Priming, the Extrafollicular B Cell Response, and
Nonspecific Accumulation of Recirculating Lymphocytes in the Nodes
Draining the Site of Challenge with Antigen. The first phenom-
enon observed after footpad challenge with MMTV(SW) or
NP-CGG is a relatively nonselective increase in the number
of lymphocytes in the draining nodes after injection of ei-
ther of the test antigens (Fig. 2, a and b). The numbers of B
cells, CD41 T cells, and CD81 T cells in the draining LN
double in the first 2 d after MMTV(SW) infection or NP-
CGG injection, but this is not associated with proliferation
(Fig. 2, c–f, Fig. 3 a). By the end of day 3 after immuniza-
tion CD41 T cell proliferation is marked in the response to
both antigens (see Fig. 2, c and d). In the MMTV(SW)-immu-
nized mice this is mainly associated with Vb61 T cells
(Figs. 2, c and 3 d); it is seen throughout the T zone and is
associated with MHC class II1 IDC (Fig. 3 b) rather than
B2201 B cells (Fig. 3 c). The T zone proliferative response
of CD41 T cells continues through day 5 when the pro-
portion of Vb61 T cells in the nodes draining MMTV(SW)
infection reaches its highest, at z30% of all CD41 T cells
(Fig. 4 a). On day 5, much of the T cell proliferation is in
association with B2201 B cells on the edge of the T zone
Figure 4. Quantitative analysis
of T and B cell subsets within the
draining popliteal LN respond-
ing to MMTV(SW) (a, c), or
alum-precipitated NP-CGG plus
B. pertussis (b, d). Cell suspen-
sions were analyzed by flow cy-
tometry as in Fig. 2. Values in a
and b represent mean numbers of
cells/node in different CD41,
Vb subsets and those in c and d
mean numbers of CD42CD82
cells/node sorted on the basis of
their expression of IgD and
B220. The same control re-
sponses were included as for Fig.
2. Three mice were analyzed for
each immunization at each time-
point.
Figure 5. Photomicrographs
showing extrafollicular B cell
proliferation in response to
MMTV(SW). Draining LN
were taken 5 d after infection
with MMTV(SW) and stained
for IgD (brown), BrdU incorpo-
ration (red), and in blue either
syndecan-1 in a (3250) or Vb6
in b (3500). Syndecan-11 plas-
mablasts are largely seen prolifer-
ating within the medullary cords
(M). At this stage, Vb61 T cells
comprise z30% of T cells and
are almost all located in the T
zone (T) where some are in cell
cycle. Very few Vb61 cells are in
the medulla and some of those
that are there are likely to be in
the efferent lymphatic channels
rather than the medullary cords.
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and less with IDC; this may reflect a shift from the T cell
priming stage to one where primed T cells are proliferating
after making cognate interaction with B cells that are ex-
pressing SAg.
There is some B cell proliferation on day 3 (see Fig. 2,
e and f) but this is far more marked on day 5 when it is
mainly associated with B2201 cells in the medullary cords;
many of these blasts have started to express syndecan-1
(Fig. 4, c and d; 5 a, 6, a and b). By day 8, the cells in the
medullary cord blasts are syndecan-11 B2202 nonprolifer-
ating plasma cells with cytoplasmic IgM or IgG (data not
shown). Most of these plasma cells are gone by day 12 in
the MMTV(SW) response; they are more persistent in the
response to NP-CGG (Fig. 6, a and b). At the height of the
B cell proliferative response to MMTV(SW) in the medul-
lary cords there are abundant Vb61 T cells in the T zone
but very few of these cells are associated with the prolifer-
ating B cells in the medullary cords (see Fig. 5 b). This re-
flects the finding that antigen-specific T cells are not obvi-
ous in extrafollicular foci of B cell proliferation in the
spleen during responses to protein antigen (29, 30).
In parallel with B cell proliferation in the medullary cords,
there is further accumulation of surface sIgD1 B cells in the
nodes. This peaks at day 5, but increased numbers of these
cells are present through 30 d after immunization with ei-
ther antigen (see Fig. 4, c and d). The bulk of the sIgD1 B
cells are in the follicles and the increased number of these
cells seems likely to be due to an increased capacity of the
node to accommodate recirculating B cells.
Follicular B and T Cell Responses. Germinal center for-
mation is already visible by day 5 after immunization with
NP-CGG in the draining nodes (Fig. 6 b). Overt germinal
centers do not appear in the MMTV(SW)-infected mice
until day 12 (Fig. 6 a); despite their late appearance and
rather small size (Fig. 7 b), they persist over weeks and are
occasionally still observed after 120 d (data not shown).
Some clusters of PNA1 cells were seen in the follicles of
draining nodes 5 d after footpad injection of MMTV(SW),
but these had gone by day 8. It seems possible that the first
cohort of activated B cells that migrate to the follicles in
these mice undergo apoptosis within a short period. Possi-
ble reasons for this are discussed below.
The retention of antigen on follicular dendritic cells is
important in the selection of B cells that have mutated their
Ig V-region genes in germinal centers (reviewed in refer-
ence 31). In the mice immunized with NP-CGG, antigen
was clearly seen on follicular dendritic cells in the draining
nodes from day 8. The viral envelope protein gp52 was also
visibly localized on follicular dendritic cells 8 d after immu-
nization with MMTV(SW) (data not shown). In both in-
stances, the localization of antigen coincided approximately
with the peak of the extrafollicular antibody response against
the immunizing antigen. The delay in the appearance of
fully developed germinal centers in the MMTV(SW)-infected
mice does not seem to be attributable to lack of antigen on
follicular dendritic cells.
T cells accumulate in the follicles in both groups of mice
from day 3 onward. The T cells associated with germinal
centers in MMTV(SW)-infected mice are mainly Vb61
(Fig. 7, c and d) and are notable for their lack of prolifera-
tion. In contrast, the T cells that appear in the follicles in
response to NP-CGG do proliferate; this T cell prolifera-
tion is in the follicular mantle as well as in the germinal
center (Fig. 7 a). This histological finding is reflected in the
persistence of BrdU-labeled CD41 T cells identified by
flow cytometry in lymph node cell suspensions from NP-
CGG-immunized mice taken on day 8 and day 12 (see Fig.
2 d) in contrast with the minimal proliferation at that stage
in the MMTV(SW)-infected mouse lymph node suspen-
sions (see Fig. 2 c). In common with previous findings, T cell
proliferation is mainly associated with the first 2 wk of the
primary follicular response (30).
Typically, the response to MMTV(SW) injection is asso-
ciated with depletion of Vb61, CD41 T cells from nonre-
sponding lymphoid organs (7). In contrast with this, Vb61
T cells persist in the responding popliteal node through day
30. These are distributed both in germinal centers where
Figure 6. Semiquantitative histological analysis of B cell proliferation
and differentiation within the draining LN following immunization with
(a) MMTV(SW) or (b) NP-CGG. Slides from the histological study were
assessed by two people independently as the extent of reaction in arbitrary
units (zero 5 the level seen in nonimmunized mice, and 3 5 a maximum
response) and the scores for three mice in each group at each timepoint
are averaged. Plasma cells and plasmablasts were identified as being synde-
can-11; blasts are defined as BrdU1 cells. Germinal centers were identi-
fied as PNA1B2201IgD2 areas.
557 Luther et al.
Figure 7. Photomicrographs
of stained sections to show ger-
minal centers formed during re-
sponses to NP-CGG in a and
MMTV(SW) in b–d within the
draining LN. a (3250) shows a
LN taken 8 d after immunization
with NP-CGG stained for IgD
(brown), CD3 (blue) and BrdU
(red) incorporation. Proliferating
T cells can be seen both within
the IgD2 germinal center (G)
and the surrounding IgD1 follic-
ular mantle (FM). b–d (3160) are
serial sections from a draining
node 22 d after infection with
MMTV(SW) stained for IgD
(brown), BrdU (red) and blue
staining which shows PNA in b,
Vb6 in c, and CD3 in d, respec-
tively. Almost all the T cells
within the PNA1 germinal cen-
ter (G) and around 10% of the T
cells in the T zone (T) express
Vb6. Very few follicular Vb6 T
cells are BrdU1; this applied to T
cells in follicles at all stages of the
response to MMTV(SW).
Figure 8. Summary of the
major events of the lymph node
immune response to either
MMTV(SW) superantigen or to
NPCGG. This sketch summa-
rizes the responses that were
quantified by flow cytometry
(Figs. 2 and 4) and localized by
immunocytochemistry. (Figs. 3,
5–7). Emphasis is put on the sites
of T and B cell activation and
differentiation with symbols rep-
resenting the relative number of
cells in a given compartment.
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Vb61 cells are the dominant T cell type and in the T zones
where they comprise about 10% of T cells (Fig. 7, c and d).
In addition, there is still substantial nonspecific T cell reten-
tion in the T zone of draining nodes 30 d after immuniza-
tion with either antigen (see Fig. 2, a and b).
Control Responses. To test whether the addition of B.
pertussis to NP-CGG was responsible for the early germinal
center formation, mice were injected with alum-precipi-
tated antigen in the absence of B. pertussis. B cell prolifera-
tion was well established by day 5 (see Fig. 2 f), although
this was at a considerably lower level than that seen when
B. pertussis was included. Histological analysis confirms that
antigen-specific B cell proliferation occurred both in the
follicles and medullary cords, and germinal center forma-
tion was not delayed compared with that seen when B. per-
tussis was given with the antigen. This microorganism en-
hances the level of the specific (and nonspecific) immune
responses to NP-CGG without affecting the timing or pat-
tern of the response. Another group of mice was immu-
nized with B. pertussis in combination with a protein-free
alum precipitate. This induced nonspecific retention of T
and B cells in the draining nodes (see Fig. 2 b) and was as-
sociated with a small follicular and medullary cord reaction,
which was somewhat delayed compared with the reaction
to NP-CGG. The response to NP-CGG alone or B. pertus-
sis plus protein-free alum precipitate was appreciably smaller
than the response to the combination of alum-precipitated
NP-CGG plus B. pertussis.
The immune reactions observed in response to MMTV(SW)
are a consequence of the retroviral infection process and the
expression of viral proteins, most notably of the SAg. To
separate SAg-induced from anti-viral effects MMTV(SW)
was injected into BALB.D2 mice. These animals are con-
genic with BALB/c mice but constitutively express the
Mtv7 SAg that binds Vb6. BALB.D2 mice consequently lack
the Vb6 T cells that react with the SAg of MMTV(SW).
No significant increase in T or B cell numbers was noted in
the draining nodes of BALB.D2 mice on day 5, day 8, and
day 16 after the injection of MMTV(SW) (see Fig. 2 a).
The histological appearance of these nodes was similar to
those of nonimmunized mice and to groups of mice in-
jected with virus-free milk, with no obvious proliferative
responses and no germinal center formation. These findings
confirm the crucial role of the SAg for all the events of
lymphocyte proliferation and differentiation described for
MMTV(SW) infection in BALB/c mice. It also indicates
that the other viral proteins by themselves are not inducing
any measurable immune response in this host.
Discussion
The lymphoid architecture involved in specific immune
responses has been investigated mainly using model anti-
gens and rarely with infectious agents. Here, we compared
the histological appearance of lymph nodes after subcutane-
ous injection of a T-dependent haptenated protein (NP-
CGG) with a murine retrovirus (MMTV) that expresses a
SAg soon after infection. We show that the extrafollicular
T and B cell activation during both responses are remark-
ably similar. Both antigens induced germinal centers, al-
though these were smaller and appeared later in the re-
sponse to MMTV(SW). The sequence of the responses to
these two antigens are summarized diagrammatically in Fig. 8.
The Role of SAg in the Response to MMTV(SW). The
BALB/c and BALB.D2 mouse strains are congenic for a
single Mtv locus, Mtv7. Due to Mtv7 SAg expression,
BALB.D2 lack T cells reactive with MMTV(SW) and there-
fore cannot mount a SAg response to this virus strain. We
have taken advantage of this strain difference to separate the
SAg-induced effects from conventional responses to other
MMTV proteins. As these proviruses are inherited as self-
antigens, all laboratory mice should be tolerant to most
MMTV peptides. The BALB/c genome contains three en-
dogenous Mtv loci (Mtv6, Mtv8, and Mtv9); only some of
these encode complete envelope protein (32, 33), but all of
them encode functional SAgs. Tolerance of T cells to the
endogenously expressed Mtv SAg has clearly been demon-
strated by neonatal deletion of specific Vb T cell subsets
(reviewed in reference 1). As a consequence, BALB.D2 mice,
lacking Vb6-expressing T cells, fail to respond to the Vb6-
specific MMTV(SW) but not to the Vb2-specific MMTV
(C4) or Vb14-specific MMTV(C3H) (2; our unpublished
results). It is not clear yet whether these animals display T
cell tolerance to endogenously encoded viral envelope pro-
teins. Here, we show that BALB.D2 mice, contrary to
BALB/c mice, fail to mount a proliferative T and B cell re-
sponse to infectious MMTV(SW), suggesting tolerance to
the viral SAg as well as to the viral peptides. These results
suggest that SAg is an essential element of the response of
BALB/c mice to MMTV(SW) and not simply an interest-
ing and efficient alternative to conventional help evoked by
these peptides.
The Specificity of the B Cell Response to MMTV(SW).
As antibodies specific for viral envelope protein gp52 were
produced from day 3 after immunization, it seems that a
proportion of the B cells that were induced to proliferate in
the medullary cords were specific for viral envelope anti-
gen. Relatively few B cells seed extrafollicular foci in the
spleen during T cell–dependent responses (15) and these go
through 6–7 cell cycles before differentiating to become
plasma cells (16, 19). The medullary cord responses to
MMTV(SW) and NP-CGG seem similar to the responses
in splenic extrafollicular foci in which small numbers of ac-
tivated B cells initiate the response. If this is the case, spe-
cific antibody production would only be expected if there
is a bias towards the activation of B cells that have specific-
ity for MMTV(SW) envelope protein. Two factors may
contribute to the specificity of the response: (a) virus entry
to the B cells may be greatly facilitated if the B cells express
surface immunoglobulin that is specific for viral envelope
proteins, and (b) appropriate engagement of the B cell re-
ceptor by antigen leads B cells to migrate to the T zones of
secondary lymphoid organs where they seek interaction
with primed T cells specific for the processed antigen. B cells
that have not engaged antigen through their antigen-spe-
cific receptors do not appear to interact with primed T cells.
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Memory B cells in the spleen, which are resident in the
marginal zones, move rapidly to the T zone after they have
picked up antigen from the marginal zone blood sinusoids
(28). On reaching the T zone they make rapid cognate in-
teraction with primed T cells, producing Ig switch tran-
scripts within 12 h of encountering antigen (19). Then the
B blasts move into the red pulp or follicles where they pro-
liferate further.
In the case of MMTV(SW), 60% of all local B blasts
were found to be infected 6 d after footpad injection (2). In
this study, we demonstrate that these B blasts, and therefore
the infection, localize to the medullary cords. It will be in-
teresting to determine the fate of these B blasts and their
role in virus persistence.
As previously discussed, T cells should be tolerant to en-
dogenously produced MMTV(SW) envelope protein. As B
cells are continuously produced from hemopoietic cells in
the marrow, there can be expected to be a steady output of
cells specific for envelope protein. B cells that have speci-
ficity for antigens expressed by cells in the marrow may be
deleted in situ (34, 35). On the other hand, most newly
produced virgin B cells leave the marrow and migrate to
the outer T zone of the secondary lymphoid organs (36, 37);
if on the way they have taken up antigen not bound to cells
and they encounter primed helper T cells in the T zone,
they can be recruited into an antibody response (38). The
MMTV(SW) envelope protein-specific B cells may be rep-
resentatives of these cells. If the antigen-charged cells fail to
find T help they stay in the T zone for up to 3 d, after
which time they die (39). This may be the situation if en-
dogenously encoded envelope protein is presented, for T cell
tolerance to viral peptides presumably exists. After MMTV
infection of B cells and SAg expression efficient T help can
be obtained. The SAg response therefore might override
B cell tolerance to viral antigens.
The Requirement for Conventional Priming of T Cells.
Recirculating T cells migrate between the T zones of sec-
ondary lymphoid organs (40, 41). In the T zones they screen
the surface of IDC; if they find MHC class II–peptide or
MHC class II–SAg they recognize they are selectively re-
tained and activated. This process seems to be fundamental
to T cell priming in most situations (10). Although B cell–
depleted mice show reduced growth of the number of anti-
gen-specific T cells after primary immunization they still
show T cell priming (42, 43). A requirement of IDC for
priming has to be distinguished from the major role B cells
can play in the subsequent expansion of clones of primed T
cells (30, 42). This effect might have been important in the
continued proliferation of Vb61 T cells seen on day 5 after
immunization with MMTV(SW). Evidence has been pre-
sented showing that virgin T cells are switched off, rather
than primed on encounter with antigen-presenting B cells
(reviewed in 44).
There appears to be a requirement for IDC for T cell
priming in the response to MMTV(SW) SAg. Vb61 T cells
were first seen to proliferate in the T zone in association
with IDC rather than B cells. In addition, SAg-specific vir-
gin T cells are present in virtually unlimited numbers (10%
of all T cells); the delay until the third day before T cell pro-
liferation can not plausibly be attributable to a lack of
SAg-specific T cells. Although this delay could be due to
the low frequency of initially infectable B cells, the rapid
onset of the medullary cord blast reaction after the onset of
T cell proliferation suggests B cells specific for viral enve-
lope protein were ready and waiting for encounter with
primed T cells. In conclusion, our evidence suggests that vir-
gin Vb61 T cells are initially not activated by SAg-express-
ing B cells but dendritic cells. We are currently testing this
hypothesis.
It is not clear how SAg is acquired by the IDC that
prime Vb61 T cells in the MMTV(SW) response. After in-
jection of MMTV(SW), infection classically has been asso-
ciated first with B cells (8). Endogenous Mtv SAg can be
presented in mice congenitally lacking B cells (45, 46), al-
though the capacity of spleen cells from these mice to in-
duce proliferation of T cells expressing the appropriate Vb
was found to be 100-fold less than that of mice with B cells
(46). Similar data are lacking for the expression of exoge-
nous MMTV SAg and it remains to be shown whether
IDC are infected, or perhaps acquire SAg passively from
other cells that have been infected. Soluble SAg has been
described (47–49), as has the secretion of loaded MHC
class II molecules by B cells (50).
The Follicular Responses. The follicular response to NP-
CGG was visible 5 d after immunization in parallel to the
extrafollicular B cell response. Germinal centers induced
by MMTV(SW) were unusual in that they were delayed
by several days and were smaller (Fig. 8). There were
signs of isolated PNA-binding cells in the follicles of the
MMTV(SW)-infected mice 5 d after immunization, but
none on day 8. This raises the possibility that the follicular
response is aborted by a massive output of virus from B
blasts proliferating in the medullary cords at that time.
Temporary dissolution of established germinal centers in-
duced by soluble antigen has been reported by a number of
groups (51–53). By day 8, the production of antibody
against viral envelope protein could result in the clearance
of most virus in the extracellular fluid; after this, germinal
centers might be expected to emerge. This hypothesis is
supported by the recent histological analysis of VSV infec-
tion in mouse spleen where virus-specific germinal center
started to arise from day 6 onward; this virus is thought to
be cleared within 24 h after infection (54). It is also possible
that the T cell priming or the interaction between primed
T cells and MMTV(SW)-infected B cells in the T zone pro-
motes extrafollicular B cell growth but is in some way inef-
fective in inducing germinal center formation. The IgG2a
dominance of the early antibody response to MMTV (8, 9)
may reflect IFN-g production and bias towards a TH1 re-
sponse and against early germinal center formation. If this is
the case, the effect is short-lived, for germinal centers were
established by day 12 after infection and then persisted for
weeks. These were still present at 30 d after immunization
and they may provide foci of chronically infected B cells.
This is supported by the finding that mice deficient in B7
interactions, that are unable to form germinal centers, show
560 Superantigen and Conventional Lymphocyte Activation In Vivo
poor virus dissemination and do not complete the virus life
cycle (55).
The T cells in the germinal centers in MMTV(SW) mice
were predominantly Vb61, implying that centrocytes are
infected by virus and their selection is SAg driven. This
raises the interesting possibility that selection of centrocytes
could be based on SAg expression rather than the presenta-
tion of peptides from antigen picked up from follicular
dendritic cells. This may not be the case, because the per-
sistence of antibody against viral envelope proteins suggests
that antigen-specific cells continue to hold some selective
advantage. Perhaps germinal center B cells in vivo have to
bind antigen through their surface Ig as well as receiving
signals from local T cells. Viral envelope protein was found
in the present study to be bound to follicular dendritic cells
from day 8 after immunization.
Regulation of the Number of Antigen-reactive T Cells. The ex-
trafollicular growth of SAg-reactive T cells on the third to
eighth day after infection is followed by massive systemic
loss of Vb61 T cells in the second week (7), but the
present study shows that Vb61 T cells in the follicles and
T zones of the responding node are spared; this suggests
regulation of numbers rather than indiscriminate deletion.
Stimulation with specific antigen has been reported previ-
ously to block SAg-induced deletion of T cells (56–58).
The combination of immunohistochemistry and flow
cytometry has provided a powerful approach to pinpoint
the activation and differentiation stages of lymphocytes in a
primary immune response in situ. The results suggest that
the MMTV(SW)-encoded superantigen leads to cognate
interactions similar to those induced by MHC peptide. IDCs
seem to play a major role in priming SAg-specific T cells. It
is followed by a cognate interaction between primed T
cells and infected virus-specific B cells at the edge of the T
zone. Those B cells migrate into the medullary cords, where
they clonally expand and differentiate into plasma cells in
the virtual absence of T cell help. This extrafollicular B cell
differentiation results in the amplification of the virus infec-
tion as well as in the secretion of virus envelope–specific
antibodies. Later, interaction occurs between virus-infected
B cells and SAg-specific T cells in germinal centers. The sus-
tained follicular response may be important in maintaining
virus infection and completing the virus life cycle.
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